These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20224821)

  • 21. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
    Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
    Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Examination of different factors influencing the vascularization of human cutaneous melanoma].
    Kiss J
    Magy Onkol; 2008 Dec; 52(4):385-9. PubMed ID: 19068467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic insights into the antileukemic activity of hyperforin.
    Billard C; Merhi F; Bauvois B
    Curr Cancer Drug Targets; 2013 Jan; 13(1):1-10. PubMed ID: 22924417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass spectral characterization of phloroglucinol derivatives hyperforin and adhyperforin.
    Sleno L; Daneshfar R; Eckert GP; Müller WE; Volmer DA
    Rapid Commun Mass Spectrom; 2006; 20(18):2641-8. PubMed ID: 16912989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells.
    Quiney C; Billard C; Mirshahi P; Fourneron JD; Kolb JP
    Leukemia; 2006 Apr; 20(4):583-9. PubMed ID: 16467866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
    Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
    J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperforin depletes synaptic vesicles content and induces compartmental redistribution of nerve ending monoamines.
    Roz N; Rehavi M
    Life Sci; 2004 Oct; 75(23):2841-50. PubMed ID: 15464835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
    Charchoglyan A; Abrahamyan A; Fujii I; Boubakir Z; Gulder TA; Kutchan TM; Vardapetyan H; Bringmann G; Ebizuka Y; Beerhues L
    Phytochemistry; 2007 Nov; 68(21):2670-7. PubMed ID: 17643455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biosynthesis of the hyperforin skeleton in Hypericum calycinum cell cultures.
    Klingauf P; Beuerle T; Mellenthin A; El-Moghazy SA; Boubakir Z; Beerhues L
    Phytochemistry; 2005 Jan; 66(2):139-45. PubMed ID: 15652570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.
    Schempp CM; Kirkin V; Simon-Haarhaus B; Kersten A; Kiss J; Termeer CC; Gilb B; Kaufmann T; Borner C; Sleeman JP; Simon JC
    Oncogene; 2002 Feb; 21(8):1242-50. PubMed ID: 11850844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hyperforin derivative IDN5706 occludes spatial memory impairments and neuropathological changes in a double transgenic Alzheimer's mouse model.
    Cerpa W; Hancke JL; Morazzoni P; Bombardelli E; Riva A; Marin PP; Inestrosa NC
    Curr Alzheimer Res; 2010 Mar; 7(2):126-33. PubMed ID: 19939230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant hyperforin up-regulates VEGF in CNS tumour cells.
    Tassone E; Maran C; Masola V; Bradaschia A; Garbisa S; Onisto M
    Pharmacol Res; 2011 Jan; 63(1):37-43. PubMed ID: 20883786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis.
    Dell'Aica I; Niero R; Piazza F; Cabrelle A; Sartor L; Colalto C; Brunetta E; Lorusso G; Benelli R; Albini A; Calabrese F; Agostini C; Garbisa S
    J Pharmacol Exp Ther; 2007 May; 321(2):492-500. PubMed ID: 17289834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperforin: To Be or Not to Be an Activator of TRPC(6).
    Friedland K; Harteneck C
    Rev Physiol Biochem Pharmacol; 2015; 169():1-24. PubMed ID: 26384487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro antitumor activity evaluation of hyperforin derivatives.
    Sun F; Liu JY; He F; Liu Z; Wang R; Wang DM; Wang YF; Yang DP
    J Asian Nat Prod Res; 2011 Aug; 13(8):688-99. PubMed ID: 21751836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phloroglucinol derivatives guttiferone G, aristoforin, and hyperforin: inhibitors of human sirtuins SIRT1 and SIRT2.
    Gey C; Kyrylenko S; Hennig L; Nguyen LH; Büttner A; Pham HD; Giannis A
    Angew Chem Int Ed Engl; 2007; 46(27):5219-22. PubMed ID: 17516596
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.
    Dinamarca MC; Cerpa W; Garrido J; Hancke JL; Inestrosa NC
    Mol Psychiatry; 2006 Nov; 11(11):1032-48. PubMed ID: 16880827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of hyperforin analogues. Part I. Modification of the enolized cyclohexanedione moiety.
    Verotta L; Appendino G; Belloro E; Bianchi F; Sterner O; Lovati M; Bombardelli E
    J Nat Prod; 2002 Apr; 65(4):433-8. PubMed ID: 11975475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.